Tuesday, November 24, 2009, 11:42pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

Haemonetics Corp. (HAE)

 At 16:02 EST: 54.98 USD  Up 0.24 (0.44%)  
MORE ON HAE
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
HAEMONETICS CP (NYSE:HAE) Delayed quote dataEdit
After Hours: 54.30 Down 0.68 (1.24%) as of 4:10pm EST on 11/24/09
Last Trade: 54.98 USD
Trade Time: 4:02PM EST
Change: Up 0.24 (0.44%)
Prev Close: 54.74
Open: 54.74
Bid: N/A
Ask: N/A
1y Target Est: 59.33
Day's Range: 53.96 - 55.01
52wk Range: 46.78 - 65.34
Volume: 342,804
Avg Vol (3m): 190,659
Market Cap: 1.41B
P/E (ttm): 24.65
EPS (ttm): 2.23
Div & Yield: N/A (N/A%)
Haemonetics Corp. (HAE)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add HAE to Portfolio   Download Data

HEADLINES
• Coverage initiated on Haemonetics by Morgan Keegan
Briefing.com (Wed, Nov 18)
• 4-Star Stocks on the Upswing
at Motley Fool (Tue, Nov 17)
• CFN Enters Agreement with Masimo
Zacks.com (Fri, Nov 13)
• HAEMONETICS CORP Financials
EDGAR Online Financials (Tue, Nov 10)
• Masimo Beats Zacks Estimate
Zacks.com (Mon, Nov 9)
• Haemonetics: Cutting-Edge Innovation
at TheStreet.com (Mon, Nov 9)
• HAEMONETICS CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Wed, Nov 4)
• Haemonetics Reports Strong Results
Zacks.com (Tue, Nov 3)
• Plasma revenue lifts Haemonetics fiscal 2Q profit
AP (Mon, Nov 2)
• Haemonetics Corporation Earnings Call scheduled for 10:00 am ET today
CCBN (Mon, Nov 2)
• HAEMONETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Mon, Nov 2)
• Haemonetics Reports Double Digit Growth in Earnings for Second Quarter Fiscal 2010 Company Affirms Full Year Revenue and EPS Guidance
PRNewswire (Mon, Nov 2)
• Q2 2010 Haemonetics Corporation Earnings Release - Before Market Open
CCBN (Mon, Nov 2)
More Headlines for HAE...
ANALYST
EPS Est (next year) (Mar-08) : 2.10
EPS Est (in 2 years) (Mar-09) : 2.46
Avg Rec (current)*: 2.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Haemonetics Corporation designs, manufactures, and markets automated systems for blood donors and surgical patients worldwide. It also markets data management systems for blood and plasma collection agencies.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices